Since TFEB amplification is associated with a more aggressive clinical manifestation and poor outcomes for renal cell carcinoma, efforts have been made to accurately diagnose patients with TFEB translocations for improved patient management (141). The gene discussed is TFEB; the disease is hereditary clear cell renal cell carcinoma.